Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1995 Jun;69(6):3475–3481. doi: 10.1128/jvi.69.6.3475-3481.1995

Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.

A Pekosz 1, C Griot 1, K Stillmock 1, N Nathanson 1, F Gonzalez-Scarano 1
PMCID: PMC189060  PMID: 7745694

Abstract

La Crosse virus, a member of the California serogroup of bunyaviruses, is an important cause of pediatric encephalitis in the midwestern United States. Like all bunyaviruses, La Crosse virus contains two glycoproteins, G1 and G2, the larger of which, G1, is the target of neutralizing antibodies. To develop an understanding of the role of each of the glycoproteins in the generation of a protective immune response, we immunized 1-week-old mice with three different preparations: a vaccinia virus recombinant (VV.ORF) that expresses both G1 and G2, a vaccinia virus recombinant (VV.G1) that expresses G1 only, and a truncated soluble G1 (sG1) protein prepared in a baculovirus system. Whereas VV.ORF generated a protective response that was mostly directed against G1, VV.G1 was only partially effective at inducing a neutralizing response and at protecting mice from a potentially lethal challenge with La Crosse virus. Nevertheless, a single immunization with the sG1 preparation resulted in a robust immune response and protection against La Crosse virus. These results indicate that (i) the G1 protein by itself can induce an immune response sufficient for protection from a lethal challenge with La Crosse virus, (ii) a neutralizing humoral response correlates with protection, and (iii) the context in which G1 is presented affects its immunogenicity. The key step in the defense against central nervous system infection appeared to be interruption of a transient viremia that occurred just after La Crosse virus inoculation.

Full Text

The Full Text of this article is available as a PDF (369.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrew M. E., Boyle D. B., Whitfeld P. L., Lockett L. J., Anthony I. D., Bellamy A. R., Both G. W. The immunogenicity of VP7, a rotavirus antigen resident in the endoplasmic reticulum, is enhanced by cell surface expression. J Virol. 1990 Oct;64(10):4776–4783. doi: 10.1128/jvi.64.10.4776-4783.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beaty B. J., Calisher C. H. Bunyaviridae--natural history. Curr Top Microbiol Immunol. 1991;169:27–78. [PubMed] [Google Scholar]
  3. Bishop D. H. Genetic potential of bunyaviruses. Curr Top Microbiol Immunol. 1979;86:1–33. doi: 10.1007/978-3-642-67341-2_1. [DOI] [PubMed] [Google Scholar]
  4. Brochier B., Kieny M. P., Costy F., Coppens P., Bauduin B., Lecocq J. P., Languet B., Chappuis G., Desmettre P., Afiademanyo K. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature. 1991 Dec 19;354(6354):520–522. doi: 10.1038/354520a0. [DOI] [PubMed] [Google Scholar]
  5. Elliott R. M. Molecular biology of the Bunyaviridae. J Gen Virol. 1990 Mar;71(Pt 3):501–522. doi: 10.1099/0022-1317-71-3-501. [DOI] [PubMed] [Google Scholar]
  6. Endres M. J., Jacoby D. R., Janssen R. S., Gonzalez-Scarano F., Nathanson N. The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein. J Gen Virol. 1989 Jan;70(Pt 1):223–228. doi: 10.1099/0022-1317-70-1-223. [DOI] [PubMed] [Google Scholar]
  7. Endres M. J., Valsamakis A., Gonzalez-Scarano F., Nathanson N. Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones. J Virol. 1990 May;64(5):1927–1933. doi: 10.1128/jvi.64.5.1927-1933.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fazakerley J. K., Gonzalez-Scarano F., Strickler J., Dietzschold B., Karush F., Nathanson N. Organization of the middle RNA segment of snowshoe hare Bunyavirus. Virology. 1988 Dec;167(2):422–432. [PubMed] [Google Scholar]
  9. Francy D. B., Karabatsos N., Wesson D. M., Moore C. G., Jr, Lazuick J. S., Niebylski M. L., Tsai T. F., Craig G. B., Jr A new arbovirus from Aedes albopictus, an Asian mosquito established in the United States. Science. 1990 Dec 21;250(4988):1738–1740. doi: 10.1126/science.2270489. [DOI] [PubMed] [Google Scholar]
  10. Fuller F., Bhown A. S., Bishop D. H. Bunyavirus nucleoprotein, N, and a non-structural protein, NSS, are coded by overlapping reading frames in the S RNA. J Gen Virol. 1983 Aug;64(Pt 8):1705–1714. doi: 10.1099/0022-1317-64-8-1705. [DOI] [PubMed] [Google Scholar]
  11. Gentsch J. R., Bishop D. H. Small viral RNA segment of bunyaviruses codes for viral nucleocapsid protein. J Virol. 1978 Oct;28(1):417–419. doi: 10.1128/jvi.28.1.417-419.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gonzalez-Scarano F. La Crosse virus G1 glycoprotein undergoes a conformational change at the pH of fusion. Virology. 1985 Jan 30;140(2):209–216. doi: 10.1016/0042-6822(85)90359-9. [DOI] [PubMed] [Google Scholar]
  13. Gonzalez-Scarano F., Shope R. E., Calisher C. E., Nathanson N. Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. Virology. 1982 Jul 15;120(1):42–53. doi: 10.1016/0042-6822(82)90005-8. [DOI] [PubMed] [Google Scholar]
  14. Gonzalez-Scarano F., Shope R. E., Calisher C. H., Nathanson N. Monoclonal antibodies against the G1 and nucleocapsid proteins of LaCrosse and Tahyna viruses. Prog Clin Biol Res. 1983;123:145–156. [PubMed] [Google Scholar]
  15. Griot C., Gonzalez-Scarano F., Nathanson N. Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses. Annu Rev Microbiol. 1993;47:117–138. doi: 10.1146/annurev.mi.47.100193.001001. [DOI] [PubMed] [Google Scholar]
  16. Griot C., Pekosz A., Lukac D., Scherer S. S., Stillmock K., Schmeidler D., Endres M. J., Gonzalez-Scarano F., Nathanson N. Polygenic control of neuroinvasiveness in California serogroup bunyaviruses. J Virol. 1993 Jul;67(7):3861–3867. doi: 10.1128/jvi.67.7.3861-3867.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jacoby D. R., Cooke C., Prabakaran I., Boland J., Nathanson N., Gonzalez-Scarano F. Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Virology. 1993 Apr;193(2):993–996. doi: 10.1006/viro.1993.1213. [DOI] [PubMed] [Google Scholar]
  18. Janssen R. S., Nathanson N., Endres M. J., Gonzalez-Scarano F. Virulence of La Crosse virus is under polygenic control. J Virol. 1986 Jul;59(1):1–7. doi: 10.1128/jvi.59.1.1-7.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Janssen R., Gonzalez-Scarano F., Nathanson N. Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab Invest. 1984 Apr;50(4):447–455. [PubMed] [Google Scholar]
  20. Kingsford L., Ishizawa L. D., Hill D. W. Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus. Virology. 1983 Sep;129(2):443–455. doi: 10.1016/0042-6822(83)90182-4. [DOI] [PubMed] [Google Scholar]
  21. Kinney R. M., Esposito J. J., Mathews J. H., Johnson B. J., Roehrig J. T., Barrett A. D., Trent D. W. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J Virol. 1988 Dec;62(12):4697–4702. doi: 10.1128/jvi.62.12.4697-4702.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Livdahl T. P., Willey M. S. Prospects for an invasion: competition between Aedes albopictus and native Aedes triseriatus. Science. 1991 Jul 12;253(5016):189–191. doi: 10.1126/science.1853204. [DOI] [PubMed] [Google Scholar]
  23. Mackett M., Smith G. L., Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol. 1984 Mar;49(3):857–864. doi: 10.1128/jvi.49.3.857-864.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Najjar J. A., Gentsch J. R., Nathanson N., Gonzalez-Scarano F. Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site. Virology. 1985 Jul 30;144(2):426–432. doi: 10.1016/0042-6822(85)90283-1. [DOI] [PubMed] [Google Scholar]
  25. Olmsted R. A., Murphy B. R., Lawrence L. A., Elango N., Moss B., Collins P. L. Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus. J Virol. 1989 Jan;63(1):411–420. doi: 10.1128/jvi.63.1.411-420.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pensiero M. N., Jennings G. B., Schmaljohn C. S., Hay J. Expression of the Hantaan virus M genome segment by using a vaccinia virus recombinant. J Virol. 1988 Mar;62(3):696–702. doi: 10.1128/jvi.62.3.696-702.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rai K. S. Aedes albopictus in the Americas. Annu Rev Entomol. 1991;36:459–484. doi: 10.1146/annurev.en.36.010191.002331. [DOI] [PubMed] [Google Scholar]
  28. Roberts A., Rossier C., Kolakofsky D., Nathanson N., Gonzalez-Scarano F. Completion of the La Crosse virus genome sequence and genetic comparisons of the L proteins of the Bunyaviridae. Virology. 1995 Jan 10;206(1):742–745. doi: 10.1016/s0042-6822(95)80001-8. [DOI] [PubMed] [Google Scholar]
  29. Schmaljohn C. S., Chu Y. K., Schmaljohn A. L., Dalrymple J. M. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol. 1990 Jul;64(7):3162–3170. doi: 10.1128/jvi.64.7.3162-3170.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schmaljohn C. S., Hasty S. E., Dalrymple J. M. Preparation of candidate vaccinia-vectored vaccines for haemorrhagic fever with renal syndrome. Vaccine. 1992;10(1):10–13. doi: 10.1016/0264-410x(92)90412-d. [DOI] [PubMed] [Google Scholar]
  31. Schmaljohn C. S., Parker M. D., Ennis W. H., Dalrymple J. M., Collett M. S., Suzich J. A., Schmaljohn A. L. Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. Virology. 1989 May;170(1):184–192. doi: 10.1016/0042-6822(89)90365-6. [DOI] [PubMed] [Google Scholar]
  32. Shope R. E., Rozhon E. J., Bishop D. H. Role of the middle-sized bunyavirus RNA segment in mouse virulence. Virology. 1981 Oct 15;114(1):273–276. doi: 10.1016/0042-6822(81)90276-2. [DOI] [PubMed] [Google Scholar]
  33. Takehara K., Morikawa S., Bishop D. H. Characterization of baculovirus-expressed Rift Valley fever virus glycoproteins synthesized in insect cells. Virus Res. 1990 Nov;17(3):173–190. doi: 10.1016/0168-1702(90)90063-h. [DOI] [PubMed] [Google Scholar]
  34. Tessier D. C., Thomas D. Y., Khouri H. E., Laliberté F., Vernet T. Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide. Gene. 1991 Feb 15;98(2):177–183. doi: 10.1016/0378-1119(91)90171-7. [DOI] [PubMed] [Google Scholar]
  35. Xu X., Ruo S. L., McCormick J. B., Fisher-Hoch S. P. Immunity to Hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins. Am J Trop Med Hyg. 1992 Oct;47(4):397–404. doi: 10.4269/ajtmh.1992.47.397. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES